{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:09:30Z","timestamp":1793210970333,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Vulvovaginal candidiasis (VVC) is a common cause of vulvovaginal itching and discharge. This article discusses the latest CDC STI Treatment Guidelines for VVC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search of relevant topics was performed, and a team of experts was convened to discuss (1) diagnosis\/testing modalities; treatment of (2) uncomplicated VVC , (3) complicated VVC, and (4) VVC caused by non-albicans yeast; (5) alternative treatment regimens; (6) susceptibility testing of yeast; Special Populations: (7) pregnancy and (8) HIV and VVC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Yeast culture remains the gold standard for diagnoses. Newer molecular assays have been developed for the diagnosis of VVC and perform well. Azole antifungals remain the treatment of choice for uncomplicated VVC. Two new drugs, TOL-463 and recently FDA-approved ibrexafungerp, appeared promising in clinical trials. For recurrent VVC, oteseconazole, not yet commercially available, may represent a new option. For non-albicans yeast infections in symptomatic patients, boric acid appears useful. No evidence supports the use of alternative treatments, including probiotics. Fluconazole during pregnancy may be associated with spontaneous abortion and craniofacial and heart defects. In women with HIV infection, lower CD4+ T-cell counts are associated with increased rates of VVC, and VVC is associated with increased viral shedding. Treatment measures in women with HIV infection are identical to those women without HIV infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There has been significant new knowledge generated about VVC since the 2015 CDC Guidelines which have led to changing recommendations.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciab1057","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T20:38:41Z","timestamp":1640810321000},"page":"S162-S168","source":"Crossref","is-referenced-by-count":144,"title":["Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines"],"prefix":"10.1093","volume":"74","author":[{"given":"Paul","family":"Nyirjesy","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Brookhart","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gweneth","family":"Lazenby","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Obstetrics and Gynecology and Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Schwebke","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack D","family":"Sobel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"2022041312504990700_CIT0001","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States.","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022041312504990700_CIT0002","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis.","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"2022041312504990700_CIT0003","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review.","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2022041312504990700_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022041312504990700_CIT0005","first-page":"1606","article-title":"The infrequent use of office-based diagnostic tests for vaginitis.","volume":"282","author":"Macio","year":"1999","journal-title":"JAMA"},{"key":"2022041312504990700_CIT0006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/AOG.0000000000002090","article-title":"Clinical validation of a test for the diagnosis of vaginitis.","volume":"130","author":"Gaydos","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2022041312504990700_CIT0007","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00252-18","article-title":"Diagnostic performance of a molecular test versus clinician assessment of vaginitis.","volume":"56","author":"Schwebke","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2022041312504990700_CIT0008","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajog.2017.08.099","article-title":"A multicenter, randomized, evaluator blinded, active-controlled study to evaluate the safety and efficacy of oral SCY-078 vs oral fluconazole in 96 subjects with moderate to severe vulvovaginal candidiasis.","volume":"217","author":"Helou","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2022041312504990700_CIT0009","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/cid\/ciy554","article-title":"Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial.","volume":"68","author":"Marrazzo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022041312504990700_CIT0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis.","volume":"214","author":"Sobel","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022041312504990700_CIT0011","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/LGT.0b013e318273e8cf","article-title":"Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the united states: Results from an internet panel survey.","volume":"17","author":"Foxman","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"2022041312504990700_CIT0012","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/LGT.0000000000000383","article-title":"Reduced antifungal susceptibility of vulvovaginal Candida species at normal vaginal pH levels: clinical implications.","volume":"22","author":"Spitzer","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"2022041312504990700_CIT0013","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/AAC.05025-11","article-title":"Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.","volume":"56","author":"Claire S.","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022041312504990700_CIT0014","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/ajd.12487","article-title":"Quality of life in patients with chronic vulvovaginal candidiasis: a before and after study on the impact of oral fluconazole therapy.","volume":"58","author":"Nguyen","year":"2017","journal-title":"Australas J Dermatol"},{"key":"2022041312504990700_CIT0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/LGT.0000000000000413","article-title":"Long-term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance antifungal therapy.","volume":"22","author":"Crouss","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"2022041312504990700_CIT0016","doi-asserted-by":"crossref","first-page":"624.e","DOI":"10.1016\/j.ajog.2018.03.001","article-title":"A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.","volume":"218","author":"Brand","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2022041312504990700_CIT0017","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis\u2014a phase 2 randomized, double-blind, placebo-controlled trial.","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2022041312504990700_CIT0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0029-7844(95)00174-P","article-title":"Saccharomyces cerevisiae vaginitis: Transmission from yeast used in baking.","volume":"86","author":"Nyirjesy","year":"1995","journal-title":"Obstet Gynecol"},{"key":"2022041312504990700_CIT0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11908-010-0137-9","article-title":"Vulvovaginal candidiasis caused by non-albicans Candida species: new insights.","volume":"12","author":"Kennedy","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"2022041312504990700_CIT0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11046-014-9780-2","article-title":"Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.","volume":"178","author":"Gamarra","year":"2014","journal-title":"Mycopathologia"},{"key":"2022041312504990700_CIT0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.mycmed.2014.05.001","article-title":"In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.","volume":"24","author":"Choukri","year":"2014","journal-title":"J Mycol Med"},{"key":"2022041312504990700_CIT0022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jiac.2015.08.008","article-title":"Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.","volume":"22","author":"Nagashima","year":"2016","journal-title":"J Infect Chemother"},{"key":"2022041312504990700_CIT0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/698736","article-title":"Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.","volume":"2013","author":"Ahmet","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2022041312504990700_CIT0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/LGT.0000000000000126","article-title":"Non-albicans Candida vulvovaginitis: treatment experience at a tertiary care vaginitis center.","volume":"20","author":"Powell","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"2022041312504990700_CIT0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11908-018-0649-2","article-title":"Candida parapsilosis vaginal infection: a new site of azole drug resistance.","volume":"20","author":"Sobel","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"2022041312504990700_CIT0026","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.mycmed.2017.07.003","article-title":"Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: a random clinical trial.","volume":"27","author":"Banaeian","year":"2017","journal-title":"J Mycol Med"},{"key":"2022041312504990700_CIT0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/japtr.JAPTR_176_16","article-title":"The effect of vaginal cream containing ginger in users of clotrimazole vaginal cream on vaginal candidiasis.","volume":"8","author":"Shabanian","year":"2017","journal-title":"J Adv Pharm Technol Res"},{"key":"2022041312504990700_CIT0028","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.19082\/6904","article-title":"Comparison of the efficacy of honey gel and clotrimazole cream in the treatment of vaginal candidiasis symptoms: a randomized clinical trial.","volume":"10","author":"Seifinadergoli","year":"2018","journal-title":"Electronic Physician"},{"key":"2022041312504990700_CIT0029","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1139\/cjm-2018-0082","article-title":"Antifungal activity of essential oils against azole-resistant and azole-susceptible vaginal Candida glabrata strains.","volume":"64","author":"Massa","year":"2018","journal-title":"Can J Microbiol"},{"key":"2022041312504990700_CIT0030","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: United States, 2002\u20132012.","volume":"79","author":"Clarke","year":"2015","journal-title":"Natl Health Stat Rep"},{"key":"2022041312504990700_CIT0031","first-page":"1","article-title":"Probiotcs and vaginal microbiology: fact or fancy?","volume":"25","author":"Buggio","year":"2019","journal-title":"BMC Women\\'s Health"},{"key":"2022041312504990700_CIT0032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12602-016-9218-x","article-title":"Comparing the recurrence of vulvovaginal candidiasis in patients undergoing prophylactic treatment with probiotic and placebo during the 6 months.","volume":"8","author":"Davar","year":"2016","journal-title":"Probiotics Antimicrob Proteins"},{"key":"2022041312504990700_CIT0033","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1097\/MCG.0000000000000225","article-title":"Can lactobacillus fermentum LF10 and lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis? A clinical study.","volume":"48","author":"Murina","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"2022041312504990700_CIT0034","first-page":"220","article-title":"Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.","volume":"41","author":"Murina","year":"2018","journal-title":"New Microbiol"},{"key":"2022041312504990700_CIT0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jam.12772","article-title":"Probiotic lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.","volume":"118","author":"Chew","year":"2015","journal-title":"J Appl Microbiol"},{"key":"2022041312504990700_CIT0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12879-015-0971-3","article-title":"Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.","volume":"15","author":"Pendharkar","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2022041312504990700_CIT0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-015-0462-0","article-title":"Vulvovaginal candidiasis in pregnancy.","volume":"17","author":"Aguin","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"2022041312504990700_CIT0038","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2015.02.009","article-title":"Exposure to fluconazole and risk of congenital malformations in the offspring: a systematic review and meta-analysis.","volume":"52","author":"Alsaad","year":"2015","journal-title":"Reprod Toxicol"},{"key":"2022041312504990700_CIT0039","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ajog.2015.11.022","article-title":"Fluconazole use and birth defects in the national birth defects prevention study.","volume":"214","author":"Howley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022041312504990700_CIT0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2015.17844","article-title":"Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth.","volume":"315","author":"M\u00f8lgaard-Nielsen","year":"2016","journal-title":"JAMA"},{"key":"2022041312504990700_CIT0041","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1503\/cmaj.180963","article-title":"Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.","volume":"191","author":"B\u00e9rard","year":"2019","journal-title":"CMAJ"},{"key":"2022041312504990700_CIT0042","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/aogs.12697","article-title":"Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome.","volume":"94","author":"Farr","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2022041312504990700_CIT0043","first-page":"4","article-title":"Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis.","volume":"21","author":"Roberts","year":"2015","journal-title":"Syst Rev"},{"key":"2022041312504990700_CIT0044","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00404-017-4331-y","article-title":"The colonization with Candida species is more harmful in the second trimester of pregnancy.","volume":"295","author":"Holzer","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2022041312504990700_CIT0045","doi-asserted-by":"crossref","first-page":"387070","DOI":"10.1155\/2014\/387070","article-title":"Determinants of symptomatic vulvovaginal candidiasis among human immunodeficiency virus type 1 infected women in rural KwaZulu-natal, South Africa.","volume":"2014","author":"Apalata","year":"2014","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2022041312504990700_CIT0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0036-46652015000200012","article-title":"Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected women.","volume":"57","author":"Alczuk","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2022041312504990700_CIT0047","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/OLQ.0000000000000513","article-title":"Prevalence and correlates of genital infections among newly diagnosed human immunodeficiency virus-infected adults entering human immunodeficiency virus care in Windhoek, Namibia.","volume":"43","author":"Gaston","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2022041312504990700_CIT0048","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/aid.2012.0269","article-title":"Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.","volume":"29","author":"Merenstein","year":"2013","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/Supplement_2\/S162\/43373987\/ciab1057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/Supplement_2\/S162\/43373987\/ciab1057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T10:12:56Z","timestamp":1726395176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/Supplement_2\/S162\/6567950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":48,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2022,4,13]]},"published-print":{"date-parts":[[2022,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab1057","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,15]]},"published":{"date-parts":[[2022,4,13]]}}}